883031-03-6
基本信息
HC-067047 >=98% (HPLC)
HC-067047
HC 067047
HC067047
1221277-90-2
2-methyl-1-(3-morpholin-4-ylpropyl)-5-phenyl-N-[3-(trifluoromethyl)phenyl]pyrrole-3-carboxamide
2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide
1H-Pyrrole-3-carboxamide, 2-methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-
物理化学性质
储存条件 | 2-8°C |
溶解度 | 在DMSO中的溶解度≥15mg/mL |
形态 | 粉末 |
颜色 | 白色至棕褐色 |
稳定性 | 从购买之日起 2 年内保持稳定。 DMSO 或乙醇溶液可在 -20℃ 下保存长达 3 个月。 |
安全数据
危险性符号(GHS) | GHS06 |
警示词 | 危险 |
危险性描述 | H301-H319 |
防范说明 | P301+P310-P305+P351+P338 |
危险品标志 | T |
危险类别码 | 25-36 |
安全说明 | 26-45 |
危险品运输编号 | UN 2811 6.1 / PGIII |
WGK Germany | 3 |
883031-03-6价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/08 | HY-100208 | 883031-03-6 HC-067047 | 883031-03-6 | 5mg | 660元 |
2024/11/08 | HY-100208 | 883031-03-6 HC-067047 | 883031-03-6 | 10mM * 1mLin DMSO | 685元 |
2024/11/08 | HY-100208 | 883031-03-6 HC-067047 | 883031-03-6 | 10mg | 1100元 |
常见问题列表
Target | Value |
mTRPV4
(Cell-free assay) | 17 nM |
hTRPV4
(Cell-free assay) | 48 nM |
rTRPV4
(Cell-free assay) | 133 nM |
HC-067047 (1 µM; 24 hours; HEI-OC1 cells) treatment significantly decreases mRNA expression in high glucose cultured HEI-OC1 cells.
HC-067047 (1 µM; 24 hours; HEI-OC1 cells) treatment significantly decreases the expression of TRPV4 protein.
HC-067047 (1 µM; 48 hours; HEI-OC1 cells) treatment inhibits cell proliferation.
HC-067047 (1 µM; 48 hours; HEI-OC1 cells) treatment promotes cell apoptosis.
RT-PCR
Cell Line: | HEI-OC1 cells |
Concentration: | 1 µM |
Incubation Time: | 24 hours |
Result: | The mRNA expression was significantly decreased. |
Western Blot Analysis
Cell Line: | HEI-OC1 cells |
Concentration: | 1 µM |
Incubation Time: | 24 hours |
Result: | The expression of TRPV4 protein was significantly decreased. |
Cell Proliferation Assay
Cell Line: | HEI-OC1 cells |
Concentration: | 1 µM |
Incubation Time: | 48 hours |
Result: | Inhibited cell proliferation. |
Apoptosis Analysis
Cell Line: | HEI-OC1 cells |
Concentration: | 1 µM |
Incubation Time: | 48 hours |
Result: | Promoted cell apoptosis. |
HC-067047 (0-50 mg/kg; intraperitoneal injection; for 30 minutes; cyclophosphamide-treated WT and Trpv4 −/− mice, and naive WT mice) treatment increases functional bladder capacity and reduces micturition frequency in WT mice with cystitis. HC-067047 do not affect bladder function in Trpv4 −/− mice.
Animal Model: | Cyclophosphamide-treated WT and Trpv4 −/− mice, and naive WT mice |
Dosage: | 0 mg/kg, 1 mg/kg, 10 mg/kg, 50 mg/kg |
Administration: | Intraperitoneal injection; for 30 minutes |
Result: | Increased functional bladder capacity and reduces micturition frequency in WT mice with cystitis and did not affect bladder function in Trpv4 −/− mice. |